Morgan Stanley Moves Veeva to Equal-weight as Shares Hit a Decade Low on Valuation
Morgan Stanley has upgraded Veeva Systems to Equal-weight, saying that the market now better understands the competitive risks facing its life-sciences CRM business following a significant drop in the stock. The firm trimmed its price target to $205 amid lower sector multiples, while noting valuation has fallen to a 10-year low on an enterprise val…